We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Cancer drugs now account for 27 percent of all new drug approvals in the U.S., up from just four percent in the 1980s — in part because of improved trial designs, novel drug formats and new targets — according to a new study from the Tufts Center for the Study of Drug Development (CSDD). Read More
Ohio Attorney General Dave Yost has asked the Sixth Circuit Court of Appeals to delay an upcoming trial of two bellwether cases brought by Cuyahoga and Summit counties against Purdue Pharma. Read More